Skip to main content
# العنوان سنة البحث
381 Pharmacotherapy of rheumatoid arthritis: an overview

2001
382 Does the dihydropyridines modify the anticonvulsant action of sodium valproate? 2001
383 A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice. 2001
384 N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice 2001
385 Modulation of the anticonvulsant action of valproic acid by verapamil against pertylentetrazol-induced seizures in mice. 2001
386 Effect of Lidocaine on the anticonvulsant properties of valproic acid against convulsions elicited by pentylenetetrazol in mice. 2001
387 The myoneural effects of Lithium chloride on the nerve-muscle preparations of rats. Role of adenosine triphosphate-sensitive potassium channels 2000
388 Influence of sodium channel blockade on the anticonvulsant properties of sodium valproate against kainic acid-induced convulsions in mice. 2000
389 Some international approaches to aminoglycoside monitoring in the extended dosing interval era. 1999
390 Combined anticonvulsant activity of verapamil and valproic acid. Pharmacodynamic interaction and influence on serum and brain electrolytes in kainic acid-treated mice. 1999